ArticleOPEN ACCESS

NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE: Efficacy and safety results

Clinical Advances in Hematology and Oncology
ISSN: 15430790
6Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE: Efficacy and safety results. (2016). Clinical Advances in Hematology and Oncology. Millennium Medical Publishing, Inc.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free